PRM.PRA Stock Overview
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Big Pharma Split Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$9.58 |
52 Week High | CA$10.78 |
52 Week Low | CA$9.18 |
Beta | 0.88 |
1 Month Change | -1.14% |
3 Month Change | -1.14% |
1 Year Change | 5.27% |
3 Year Change | -6.81% |
5 Year Change | -7.53% |
Change since IPO | -4.49% |
Recent News & Updates
Recent updates
Shareholder Returns
PRM.PRA | CA Capital Markets | CA Market | |
---|---|---|---|
7D | 0% | -1.8% | -2.1% |
1Y | 5.3% | 19.5% | 3.6% |
Return vs Industry: PRM.PRA underperformed the Canadian Capital Markets industry which returned 19.5% over the past year.
Return vs Market: PRM.PRA exceeded the Canadian Market which returned 3.6% over the past year.
Price Volatility
PRM.PRA volatility | |
---|---|
PRM.PRA Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.3% |
Market Average Movement | 9.2% |
10% most volatile stocks in CA Market | 18.4% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: PRM.PRA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PRM.PRA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | n/a | n/a | www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/ |
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Big Pharma Split Corp. Fundamentals Summary
PRM.PRA fundamental statistics | |
---|---|
Market cap | CA$15.59m |
Earnings (TTM) | -CA$645.35k |
Revenue (TTM) | CA$320.82k |
48.2x
P/S Ratio-24.0x
P/E RatioIs PRM.PRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PRM.PRA income statement (TTM) | |
---|---|
Revenue | CA$320.82k |
Cost of Revenue | CA$0 |
Gross Profit | CA$320.82k |
Other Expenses | CA$966.17k |
Earnings | -CA$645.35k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.55 |
Gross Margin | 100.00% |
Net Profit Margin | -201.16% |
Debt/Equity Ratio | 65.0% |
How did PRM.PRA perform over the long term?
See historical performance and comparison